Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

News Daily News

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Michael O'Riordan

February 24, 2023

News Conference News CRT 2018

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

Michael O'Riordan

March 06, 2018

Presentation JIM 2018

Take Home Message: Bifurcation lesions

Presenter: Alaide Chieffo

February 21, 2018

Presentation JIM 2017

EluNIR™The First Elastomeric Drug Eluting Stent (eDES™)

Presenter: Alaide Chieffo

February 09, 2017

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

Presentation TCT 2012

Update: Everything You Need to Know About Stent Thrombosis Management in 2012

Presenter: Alaide Chieffo

October 26, 2012

Presentation TCT 2012

DES Restenosis: Treatment Options and Recurrent Event Rates

Presenter: Alaide Chieffo

October 22, 2012

Presentation TCT 2012

Eight Years Clinical Outcomes After Unrestricted Sirolimus-eluting Stent Implantation for Severe Coronary Artery Disease

Presenter: Alfonso Ielasi, Azeem Latib, Marco Mussardo, Massimo Ferraro, Maria Angela Gullace, Cosmo Godino, Mauro Carlino, Matteo Montorfano, Alaide Chieffo, Antonio Colombo

January 03, 2012

CME

Advertisement

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

Take Home Message: Bifurcation lesions

EluNIR™The First Elastomeric Drug Eluting Stent (eDES™)

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Update: Everything You Need to Know About Stent Thrombosis Management in 2012

DES Restenosis: Treatment Options and Recurrent Event Rates

Eight Years Clinical Outcomes After Unrestricted Sirolimus-eluting Stent Implantation for Severe Coronary Artery Disease

What’s Next for Left Main PCI?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content